Artera presented multiple studies at the 2026 American Society of Clinical Oncology Annual Meeting showcasing how multimodal artificial intelligence (MMAI) models can improve cancer risk stratification and treatment decision-making. The research highlights the growing role of AI-powered clinical intelligence in precision oncology, where healthcare providers are increasingly using machine learning models to personalize treatment selection,... Read More
